Expertise in
8
conditions

Hacer I. Durmus

Istanbul, TR 
Expertise in
8
conditions
Istanbul, TR 

Overview

Hacer Durmus practices practicing medicine in Istanbul, Turkey.

Durmus is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Congenital Myasthenic Syndrome, Myasthenia Gravis, Primary Lateral Sclerosis, and Glycogen Storage Disease Type 5.

They are actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 2 clinical trials.

Locations

Istanbul, Turkey
Other Locations
Capa, 34390, Turkey
Fatih, 34104, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency Treated With the Combination of Pyrimidine Nucleos(t)Ides as Well as Untreated Subjects to Collect Vital Status Data and Supporting Information
A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency Treated With the Combination of Pyrimidine Nucleos(t)Ides as Well as Untreated Subjects to Collect Vital Status Data and Supporting Information
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Other
View 1 Less Clinical Trial

71 Total Publications

Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences.
Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences.
Journal: Orphanet journal of rare diseases
Published: May 09, 2026

Frequently Asked Questions about Hacer I. Durmus

Is Hacer I. Durmus a top-rated expert for Congenital Myasthenic Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Hacer I. Durmus is classified as an Distinguished expert for Congenital Myasthenic Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hacer I. Durmus participate in research or clinical trials?

Yes. Hacer I. Durmus has published 71 articles and abstracts on conditions like Congenital Myasthenic Syndrome. You can view a list of Hacer I. Durmus's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Durmus's expertise for a condition
ConditionClose
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile